Close to two years after AbbVie…
Close to two years after AbbVie handed over $48 million [...]
Close to two years after AbbVie handed over $48 million [...]
ORLANDO, Fla.—The leader of Gilead’s Kite Pharma is sure that [...]
The industry’s mRNA alliance is demanding steady FDA leadership, warning [...]
The FDA’s reported plan to move toward single-trial approvals has [...]
Encoded Therapeutics has linked its Dravet syndrome gene therapy ETX101 [...]
Having already claimed a win for the phase 2 study [...]
Pfizer’s VC arm has backed a $100 million series A [...]
The top spot at the FDA’s Center for Drug Evaluation [...]
The FDA has placed a hold on Denali Therapeutics’ plans [...]
Crescent Biopharma has agreed to pay Kelun-Biotech $80 million for [...]